Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

SBAR II: Application of SBAR

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

GATA2 mutation is associated with immune dysfunction and increased Mycobacterium haemophilum susceptibility in immunocompromised individuals.

JCI insight·2025

Same author

Leveraging Bluetooth low-energy technology to improve contact tracing among healthcare personnel in hospital setting during the coronavirus disease 2019 (COVID-19) pandemic.

Infection control and hospital epidemiology·2023

Same author

Mycobacterium haemophilum Related Myelitis in Geographically Linked Cases.

Annals of neurology·2023

Same author

Spatial Epidemiologic Analysis and Risk Factors for Nontuberculous Mycobacteria Infections, Missouri, USA, 2008-2019.

Emerging infectious diseases·2023

Same author

Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multicenter Cohort Reveal Parallel Signatures of In-Host Adaptation.

The Journal of infectious diseases·2023

Same author

Missed Opportunities in the Diagnosis of Tuberculosis Meningitis.

Open forum infectious diseases·2023

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Automated dose checking and intervention for bariatric patients.

Yan Huang¹, Richard M Reichley, Laura A Noirot

¹BJC HealthCare, St. Louis, MO, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium

|August 13, 2008

Summary

Obesity affects 33% of Americans, leading to potential antibiotic underdosing. A new automated tool checks antibiotic doses for bariatric patients to ensure appropriate treatment.

Related Experiment Videos

Last Updated: Jul 2, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Pharmacology
Public Health
Clinical Informatics

Background:

Obesity prevalence is high in the US, with 33% of the population classified as obese by the CDC.
Current antibiotic dosing guidelines are based on non-obese individuals, potentially leading to suboptimal antibiotic exposure in obese patients.
Underdosing of antibiotics in obese populations may compromise treatment efficacy and contribute to antimicrobial resistance.

Purpose of the Study:

To develop and validate an automated tool for detecting potentially inappropriate antibiotic dosing in bariatric patients.
To address the challenge of accurate antibiotic dosing in the growing obese population.

Main Methods:

Development of an automated dose checking software.
Integration of patient data, including weight and clinical context, for dose calculation.
Validation of the tool against established pharmacokinetic principles and clinical guidelines.

Main Results:

The automated tool efficiently identifies potentially inappropriate antibiotic dosages in bariatric patients.
The system flags instances where standard dosing may lead to sub-therapeutic levels.
Demonstrated feasibility of using automated systems for optimizing drug dosing in specialized populations.

Conclusions:

Automated dose checking tools are crucial for ensuring appropriate antibiotic therapy in obese patients.
This technology can help mitigate risks associated with underdosing in bariatric populations.
Implementation of such tools can improve patient outcomes and support antimicrobial stewardship efforts.